Tuesday, May 06, 2025 12:24:59 AM
https://www.globenewswire.com/news-release/2025/01/02/3003506/0/en/GCAN-to-Explore-Strategic-Alternatives-in-Artificial-Intelligence-and-Quantum-Computing.html
The Company will continue to pursue its existing biopharma lines of business while evaluating a range of strategic options to maximize value for its shareholders. The business fields of quantum computing and AI are seen as the next frontier in emerging technologies, and have quickly developed into multi-billion dollar industries.
There have been a number of companies focused on developing these cutting edge technologies who have approached GCAN expressing interest in a potential merger, and as part of our fiduciary obligation to our shareholders we will explore these options.
As part of the evaluation process GCAN will explore potential strategic alternatives that may include, but are not limited to a sale, merger, strategic business combination or other transaction.
I've been in IT for decades and I think so many don't realize the mind blowing speed Quantum Computing provides and when combined with real factual vetted AI database - off the charts explosive MACH speed!
Please donate if you can for our US Military VETs/Families -- THANK YOU!
https://independencefund.org/
https://www.woundedwarriorproject.org/
https://t2t.org/
https://specialops.org/
https://foldsofhonor.org/
https://www.dav.org/
Recent GCAN News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2026 01:00:45 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/31/2026 08:22:05 PM
- GCANRx Announces Relisting To OTCQB Market Tier • GlobeNewswire Inc. • 12/03/2025 12:45:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/16/2025 03:13:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/15/2025 11:00:32 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2025 02:05:11 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/08/2025 01:56:50 PM
